Dynamic miRNA activity identifies therapeutic targets in trastuzumab ‐resistant HER2+ breast cancer

Biotechnology and Bioengineering,Volume 0, Issue ja, -Not available-.

Source: Biotechnology and Bioengineering - July 7, 2018 Category: Biomedical Science Authors: Joseph T.Decker , Matthew S.Hall , Rachel B.Blaisdell , KallenSchwark , Jacqueline S.Jeruss , Lonnie D.Shea Source Type: research